Tevogen Bio HoldingsTVGN +0.17%10 Market Cap is $24.35 Mil as of Jul. 02, 2026. GuruFocus rates TVGN with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 1,427 Biotechnology companies, Tevogen Bio Holdings ranks worse than 73.58% on this metric.
Tevogen Bio Holdings's quarterly market cap
declined
from Sep. 2025 ($155.02 Mil) to Dec. 2025 ($66.57 Mil) and
declined
from Dec. 2025 ($66.57 Mil) to Mar. 2026 ($18.84 Mil).
Tevogen Bio Holdings's annual market cap
increased
from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($183.34 Mil) but then
declined
from Dec. 2024 ($183.34 Mil) to Dec. 2025 ($66.57 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tevogen Bio Holdings's Enterprise Value for Today is $41.93 Mil.
Tevogen Bio Holdings (NAS:TVGN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Tevogen Bio Holdings Market Cap Related Terms
Tevogen Bio Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Tevogen Bio Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Tevogen Bio Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tevogen Bio Holdings Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tevogen Bio Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Tevogen Bio Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Tevogen Bio Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tevogen Bio Holdings (TVGN) has a Market Cap of $24.35 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tevogen Bio Holdings and its competitors. According to the industry distribution chart, Tevogen Bio Holdings ranks #1050 out of 1427 companies in the Biotechnology industry, placing it in the top 73.6%.
Is Tevogen Bio Holdings' Market Cap too high?
Tevogen Bio Holdings' current Market Cap is $24.35 Mil. The Biotechnology industry median Market Cap is 119.04. Tevogen Bio Holdings' value of $24.35 Mil is 79.5% below this industry median. Based on the distribution chart, Tevogen Bio Holdings ranks #1050 out of 1427 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Tevogen Bio Holdings has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Tevogen Bio Holdings' Market Cap compare to GRDX and DYAI?
According to the Biotechnology industry distribution chart, Tevogen Bio Holdings ranks #1050 out of 1427 companies for Market Cap. This places Tevogen Bio Holdings in the lower half of its industry. The industry median Market Cap is 119.04. Tevogen Bio Holdings' value of $24.35 Mil is 79.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.04, based on 1,427 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tevogen Bio Holdings's current Market Cap of $24.35 Mil is 79.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tevogen Bio Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 119.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tevogen Bio Holdings's current Market Cap is $24.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tevogen Bio Holdings stock overvalued right now?
Tevogen Bio Holdings (TVGN) has a current Market Cap of $24.35 Mil. The current Market Cap is $24.35 Mil and 79.5% below the Biotechnology industry median of 119.04. Tevogen Bio Holdings' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Tevogen Bio Holdings (TVGN), the current Market Cap is $24.35 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
10GF Score
Get the complete analysis for TVGN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TVGN has been successfully added to your 
